title: Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States.
abstract: OBJECTIVE
  The American Urological Association (AUA) first commissioned the Gallup Organization of Princeton, New Jersey to conduct a study to assess urologists' practice patterns in 1992.
  
  
  METHODS
  In August 1994 a random sample of 514 American urologists was surveyed by the Gallup Organization regarding practice patterns for the diagnosis and management of benign prostatic hyperplasia (BPH). It asked questions regarding the practice patterns of respondents in their diagnosis and management of BPH.
  
  
  RESULTS
  The survey revealed that 99% of the respondents were aware of and used the AUA symptom score index, and that 21% of these respondents had altered their diagnosis and management strategies because of its existence.
  
  
  CONCLUSIONS
  Therapeutic recommendations of the respondents based upon AUA symptom score index severity parallel the recently announced federal Agency for Health Care Policy and Research BPH practice guidelines.
authors.affiliation: Health Policy Survey and Research Committee, American Urological Association, Baltimore, Maryland, USA.
authors.forename: W F
authors.initials: WF
authors.lastname: Gee
authors.forename: H L
authors.initials: HL
authors.lastname: Holtgrewe
authors.forename: P C
authors.initials: PC
authors.lastname: Albertsen
authors.forename: M S
authors.initials: MS
authors.lastname: Litwin
authors.forename: M J
authors.initials: MJ
authors.lastname: Manyak
authors.forename: M P
authors.initials: MP
authors.lastname: O'Leary
authors.forename: M R
authors.initials: MR
authors.lastname: Painter
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D001291:Attitude of Health Personnel; D003558:Cystoscopy; D006801:Humans; D008297:Male; D010347:Patient Care Planning; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011364:Professional Practice; D011470:Prostatic Hyperplasia / Q000175:diagnosis* / Q000628:therapy*; D012955:Societies, Medical; D014481:United States; D016270:United States Agency for Healthcare Research and Quality; D014563:Urodynamics; D014567:Urography; D014572:Urology
chemical_list: D000317:Adrenergic alpha-Antagonists